Lasa Supergenerics Ltd.
BSE: 540702 | Sector: Health care |
NSE: LASA | ISIN Code: INE670X01014 |
BSE 00:00 | 22 Jan | 87.10 |
-2.35 (-2.63%) |
OPEN
90.30 |
HIGH
91.70 |
LOW
86.35 |
NSE 00:00 | 22 Jan | 87.25 |
-1.70 (-1.91%) |
OPEN
89.90 |
HIGH
91.25 |
LOW
86.30 |
OPEN | 90.30 |
PREVIOUS CLOSE | 89.45 |
VOLUME | 23479 |
52-Week high | 100.15 |
52-Week low | 26.00 |
P/E | 20.16 |
Mkt Cap.(Rs cr) | 354 |
Buy Price | 86.50 |
Buy Qty | 60.00 |
Sell Price | 87.90 |
Sell Qty | 50.00 |
Lasa Supergenerics Ltd. (LASA) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 575.05 | 137,971.74 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,544.40 | 94,086.10 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 5,033.80 | 83,712.10 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 808.05 | 65,165.19 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 923.65 | 54,116.65 | 13,266.48 | 1,872.74 | 16,809.46 |
Lupin | 1,079.55 | 48,957.59 | 11,025.66 | 727.55 | 17,937.29 |
Biocon | 393.80 | 47,256.00 | 1,988.40 | 440.90 | 7,583.50 |
Cadila Health. | 460.30 | 47,120.91 | 6,347.40 | 1,412.90 | 15,089.80 |
Torrent Pharma. | 2,691.25 | 45,541.33 | 6,168.44 | 938.51 | 10,683.66 |
Gland Pharma | 2,282.90 | 37,325.42 | 2,633.24 | 772.86 | 3,653.86 |
Alkem Lab | 3,033.80 | 36,269.08 | 6,677.08 | 1,264.42 | 7,728.19 |
Apollo Hospitals | 2,599.80 | 36,168.42 | 9,794.50 | 470.30 | 8,570.00 |
Piramal Enterp. | 1,487.00 | 33,539.29 | 4,219.19 | 144.85 | 33,415.39 |
Abbott India | 14,414.45 | 30,630.71 | 4,093.14 | 592.93 | 2,691.43 |
Ipca Labs. | 2,045.95 | 25,952.88 | 4,367.43 | 652.46 | 4,185.23 |
Glaxosmi. Pharma | 1,517.85 | 25,713.90 | 3,224.68 | 110.05 | 2,129.60 |
Syngene Intl. | 584.65 | 23,386.00 | 2,011.90 | 411.50 | 3,313.70 |
Pfizer | 4,813.15 | 22,020.16 | 2,151.65 | 509.13 | 3,534.54 |
Laurus Labs | 370.65 | 19,889.08 | 2,797.34 | 267.05 | 2,966.39 |
Sanofi India | 8,412.40 | 19,373.76 | 3,070.60 | 414.20 | 2,496.40 |
Quick Links for Lasa Supergenerics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices